Tae-Jin Kim (Taejin Kim, Tae Jin Kim)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Radical Prostatectomy

Helicobacter Pylori

Top Venues

Yonsei medical journal

Pharmaceuticals (Basel, Switzerland)

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Hye Kyeong Kim, Tae-Jin Kim
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency. Biomolecules 14 (2) (2024)
Hye Kyeong Kim, Tae-Jin Kim
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency. Biomolecules 14 (2) (2024)
Hye Kyeong Kim, Tae-Jin Kim
Current Status and Future Prospects of Stem Cell Therapy for Infertile Patients with Premature Ovarian Insufficiency. Biomolecules 14 (2) (2024)
Tae-Jin Kim, Hyojin Kim
Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Ji-Young Choi, Tae-Jin Kim
The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer. Current issues in molecular biology 45 (4) (2023)
Tae-Jin Kim, Kyo Chul Koo
Testosterone to Luteinizing Hormone Ratio as a Potential Predictor of Sperm Retrieval in Non-Obstructive Azoospermia Patients. Yonsei medical journal 64 (7) (2023)
Ji-Young Choi, Tae-Jin Kim
The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer. Current issues in molecular biology 45 (4) (2023)
Tae-Jin Kim, Kyo Chul Koo
Testosterone to Luteinizing Hormone Ratio as a Potential Predictor of Sperm Retrieval in Non-Obstructive Azoospermia Patients. Yonsei medical journal 64 (7) (2023)
Tae-Jin Kim, Hyojin Kim
Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Tae-Jin Kim, Kyo Chul Koo
Testosterone to Luteinizing Hormone Ratio as a Potential Predictor of Sperm Retrieval in Non-Obstructive Azoospermia Patients. Yonsei medical journal 64 (7) (2023)
Tae-Jin Kim, Kyo Chul Koo
Testosterone to Luteinizing Hormone Ratio as a Potential Predictor of Sperm Retrieval in Non-Obstructive Azoospermia Patients. Yonsei medical journal 64 (7) (2023)
Tae-Jin Kim, Young Hwa Lee, Kyo Chul Koo
Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review. Investigative and clinical urology 63 (5) (2022)
Ji Young Choi, Tae-Jin Kim
Fertility Preservation and Reproductive Potential in Transgender and Gender Fluid Population. Biomedicines 10 (9) (2022)
Young Dong Yu, Tae-Jin Kim
Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Metastatic Prostate Cancer: A Comprehensive Review. International journal of molecular sciences 22 (2) (2021)
Tae-Jin Kim, Young Hwa Lee, Kyo Chul Koo
Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review. Biomolecules 11 (4) (2021)
Tae-Jin Kim, Kyo Chul Koo
Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review. Cancers 12 (6) (2020)
Tae-Jin Kim, Young Dong Yu, Dong Soo Park, Koon Ho Rha, Sung Joon Hong, Kang Su Cho, Byung Ha Chung, Kyo Chul Koo
Impact of Cerebrovascular Disease on Survival Benefits from Local Treatment in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer. Yonsei medical journal 60 (12) (2020)